| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 382.07B | 389.59B | 372.60B | 354.94B | 327.85B |
| Gross Profit | 122.39B | 268.72B | 211.40B | 250.59B | 230.47B |
| EBITDA | 96.85B | 84.01B | 109.77B | 108.48B | 104.88B |
| Net Income | 20.28B | 20.61B | 18.73B | 16.75B | 14.37B |
Balance Sheet | |||||
| Total Assets | 669.90B | 671.24B | 661.05B | 642.66B | 591.08B |
| Cash, Cash Equivalents and Short-Term Investments | 68.24B | 64.89B | 85.27B | 84.81B | 70.69B |
| Total Debt | 34.10B | 39.77B | 45.54B | 56.18B | 36.55B |
| Total Liabilities | 298.88B | 307.67B | 307.15B | 299.13B | 257.64B |
| Stockholders Equity | 368.44B | 361.05B | 351.47B | 341.62B | 332.34B |
Cash Flow | |||||
| Free Cash Flow | 22.53B | 13.66B | 23.02B | 28.07B | 38.59B |
| Operating Cash Flow | 90.17B | 89.40B | 102.39B | 100.54B | 110.64B |
| Investing Cash Flow | -69.65B | -84.66B | -85.54B | -56.11B | -74.78B |
| Financing Cash Flow | -23.80B | -24.06B | -24.52B | -23.81B | -24.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$10.40B | 4.98 | 8.45% | 7.46% | -0.06% | 1.10% | |
70 Outperform | HK$639.26B | 13.34 | 6.83% | 5.40% | 1.29% | -3.41% | |
67 Neutral | HK$234.08B | 8.58 | 6.09% | 5.29% | 0.68% | 0.64% | |
67 Neutral | HK$191.42B | ― | 4.14% | 4.03% | 2.73% | 8.45% | |
67 Neutral | HK$96.22B | 6.78 | 14.46% | 2.86% | 5.18% | 4.25% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
46 Neutral | HK$47.62B | 34.49 | -2.39% | 1.68% | 7.18% | 15.72% |